KaloBios Pharmaceutical files for bankruptcy
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] KaloBios Pharmaceuticals Inc, which fired its controversial chief executive, Martin Shkreli, earlier this month, filed for Chapter 11 bankruptcy on Tuesday in the US bankruptcy court for the District of Delaware.
The drugmaker listed both its assets and liabilities in the range of US$1 million to US$10 million.
The move comes on the heels of KaloBios' appeal of the Nasdaq decision to delist its shares.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
